Sylvia Tobé
InvestorManaging Director at JDRF T1D Fund · Principal, Climate Fund at Toyota Ventures
About
A biotech professional with over a decade of experience across venture investing, company creation, and translational science. Before the T1D Fund she was a Principal at Omega Funds focused on early-stage investing, and previously spent nearly seven years at Ra Pharmaceuticals; she holds a Ph.D. in Biochemistry from Pierre and Marie Curie University.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
DiogenXIslex TherapeuticsRectify PharmaVanqua BioZagBioZucara Therapeutics
Per the firm's website.
Colleagues at JDRF T1D Fund
Aaron J. Kowalski
Board of Directors at JDRF T1D Fund
Adam King
Vice President at GroundForce Capital
Brady Bohrmann
Investment Committee at JDRF T1D Fund
Dan McNamara
Head of Strategy & Industry Engagement at JDRF T1D Fund
Daniel Flicker
Senior Associate at JDRF T1D Fund
Elizabeth Mily
CEO at JDRF T1D Fund
Eric Shen
Chief of Staff at JDRF T1D Fund
Ethan Sohn
Principal at Toyota Ventures
Frequently asked questions
- Who is Sylvia Tobé?
- A biotech professional with over a decade of experience across venture investing, company creation, and translational science. Before the T1D Fund she was a Principal at Omega Funds focused on early-stage investing, and previously spent nearly seven years at Ra Pharmaceuticals; she holds a Ph.D. in Biochemistry from Pierre and Marie Curie University.
- Where does Sylvia Tobé work?
- Sylvia Tobé is Managing Director at JDRF T1D Fund.
- What does Sylvia Tobé invest in?
- Sylvia Tobé invests in Biotech.
- What boards does Sylvia Tobé sit on?
- Sylvia Tobé holds tracked board seats at DiogenX, Islex Therapeutics, Rectify Pharma, Vanqua Bio, ZagBio, Zucara Therapeutics.